Scientific & Clinical Due Diligence
Evidence, differentiation and risks before an investment or licensing decision.
Independent life sciences advisory
Evidence-led decisions for biotech investors, pharma teams and digital health companies.
What I do
Evidence, differentiation and risks before an investment or licensing decision.
Prioritize assets, indications and opportunities with a clear decision framework.
Translate real-world evidence and patient insights into commercial decisions.
Business development strategy, partner outreach and hands-on deal execution support.
Professional experience
Recommendations
“I can confidently say he is one of the most dedicated and skilled consultants I’ve worked with. Dennis has a strong scientific mindset, and his analytical skills are exceptional; he has a knack for digging deep into data and uncovering insights that others might miss.”
Jonas Hanske
Former Scitaris project manager · Director, Corporate Development & Strategy, BioNTech SE
1 of 3
Selected work